Zoetis (ZTS) |
United States |
$44.807B |
29.70 |
Takeda Pharmaceutical (TAK) |
Japan |
$31.419B |
11.62 |
Grifols (GRFS) |
Spain |
$13.084B |
15.86 |
Ionis Pharmaceuticals (IONS) |
United States |
$8.099B |
0.00 |
Neurocrine Biosciences (NBIX) |
United States |
$7.679B |
497.35 |
Jazz Pharmaceuticals (JAZZ) |
Ireland |
$7.560B |
10.85 |
Sage Therapeutics (SAGE) |
United States |
$7.412B |
0.00 |
Nektar Therapeutics (NKTR) |
United States |
$7.377B |
10.58 |
Loxo Oncology (LOXO) |
United States |
$7.184B |
0.00 |
Tilray (TLRY) |
United States |
$7.138B |
0.00 |
Catalent (CTLT) |
United States |
$6.055B |
25.35 |
United Therapeutics (UTHR) |
United States |
$5.167B |
8.45 |
FibroGen (FGEN) |
United States |
$4.840B |
0.00 |
Taro Pharmaceutical Industries (TARO) |
Israel |
$4.117B |
13.25 |
AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$3.953B |
21.02 |
USANA Health Sciences (USNA) |
United States |
$2.562B |
20.91 |
Endo (ENDP) |
Ireland |
$2.360B |
3.62 |
Ironwood Pharmaceuticals (IRWD) |
United States |
$2.144B |
0.00 |
Madrigal Pharmaceuticals (MDGL) |
United States |
$2.062B |
0.00 |
Heron Therapeutics (HRTX) |
United States |
$2.044B |
0.00 |
Portola Pharmaceuticals (PTLA) |
United States |
$1.980B |
0.00 |
Zogenix (ZGNX) |
United States |
$1.975B |
0.00 |
Xencor (XNCR) |
United States |
$1.972B |
0.00 |
Enanta Pharmaceuticals (ENTA) |
United States |
$1.886B |
23.49 |
Aerie Pharmaceuticals (AERI) |
United States |
$1.867B |
0.00 |
PTC Therapeutics (PTCT) |
United States |
$1.665B |
0.00 |
Arrowhead Pharmaceuticals (ARWR) |
United States |
$1.659B |
0.00 |
Pacira Pharmaceuticals (PCRX) |
United States |
$1.631B |
220.44 |
Theravance Biopharma (TBPH) |
Cayman Islands |
$1.493B |
0.00 |
TherapeuticsMD (TXMD) |
United States |
$1.363B |
0.00 |
Corcept Therapeutics (CORT) |
United States |
$1.314B |
19.29 |
Spectrum Pharmaceuticals (SPPI) |
United States |
$1.251B |
0.00 |
Esperion Therapeutics (ESPR) |
United States |
$1.193B |
0.00 |
BioCryst Pharmaceuticals (BCRX) |
United States |
$0.986B |
0.00 |
Tricida (TCDA) |
United States |
$0.936B |
0.00 |
ImmunoGen (IMGN) |
United States |
$0.819B |
0.00 |
Radius Health (RDUS) |
United States |
$0.805B |
0.00 |
Crinetics Pharmaceuticals (CRNX) |
United States |
$0.588B |
0.00 |
Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$0.562B |
0.00 |
ChemoCentryx (CCXI) |
United States |
$0.549B |
43.44 |
Siga Technologies (SIGA) |
United States |
$0.542B |
0.00 |
Flexion Therapeutics (FLXN) |
United States |
$0.537B |
0.00 |
Karyopharm Therapeutics (KPTI) |
United States |
$0.535B |
0.00 |
BioSpecifics Technologies Corp (BSTC) |
United States |
$0.495B |
29.18 |
GlycoMimetics (GLYC) |
United States |
$0.494B |
0.00 |
Forty Seven (FTSV) |
United States |
$0.479B |
0.00 |
Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.466B |
0.00 |
Collegium Pharmaceutical (COLL) |
United States |
$0.462B |
0.00 |
Odonate Therapeutics (ODT) |
United States |
$0.446B |
0.00 |
Aptorum Group (APM) |
China |
$0.429B |
0.00 |
Rigel Pharmaceuticals (RIGL) |
United States |
$0.378B |
0.00 |
Akebia Therapeutics (AKBA) |
United States |
$0.369B |
0.00 |
Lannett Co Inc (LCI) |
United States |
$0.367B |
3.41 |
ArQule (ARQL) |
United States |
$0.351B |
0.00 |
KalVista Pharmaceuticals (KALV) |
United States |
$0.338B |
0.00 |
CASI Pharmaceuticals (CASI) |
United States |
$0.334B |
0.00 |
Concert Pharmaceuticals (CNCE) |
United States |
$0.334B |
0.00 |
Majesco Entertainment (PTE) |
United States |
$0.333B |
0.00 |
Translate Bio (TBIO) |
United States |
$0.333B |
0.00 |
Tyme Technologies (TYME) |
United States |
$0.323B |
0.00 |
Dermira (DERM) |
United States |
$0.319B |
0.00 |
Verrica Pharmaceuticals (VRCA) |
United States |
$0.308B |
0.00 |
Aclaris Therapeutics (ACRS) |
United States |
$0.305B |
0.00 |
OptiNose (OPTN) |
United States |
$0.295B |
0.00 |
Minerva Neurosciences (NERV) |
United States |
$0.282B |
0.00 |
ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.279B |
10.38 |
Catalyst Pharmaceuticals (CPRX) |
United States |
$0.278B |
0.00 |
Mast Therapeutics (SVRA) |
United States |
$0.244B |
0.00 |
MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.242B |
0.00 |
Opexa Therapeutics (ACER) |
United States |
$0.227B |
0.00 |
IMV INC (IMV) |
Canada |
$0.225B |
0.00 |
Affimed (AFMD) |
Germany |
$0.217B |
0.00 |
Dova Pharmaceuticals (DOVA) |
United States |
$0.214B |
0.00 |
MEI Pharma (MEIP) |
United States |
$0.210B |
0.00 |
Aratana Therapeutics (PETX) |
United States |
$0.210B |
0.00 |
Aldeyra Therapeutics (ALDX) |
United States |
$0.209B |
0.00 |
Rafael Holdings (RFL) |
United States |
$0.207B |
0.00 |
ElectroCore (ECOR) |
United States |
$0.206B |
0.00 |
Galectin Therapeutics (GALT) |
United States |
$0.204B |
0.00 |
Calithera Biosciences (CALA) |
United States |
$0.199B |
0.00 |
Xeris Pharmaceuticals (XERS) |
United States |
$0.192B |
0.00 |
Foamix Pharmaceuticals (FOMX) |
Israel |
$0.192B |
0.00 |
Taiwan Liposome, Unsponsored ADR (TLC) |
Taiwan |
$0.189B |
0.00 |
Recro Pharma (REPH) |
United States |
$0.184B |
0.00 |
Redhill Biopharma (RDHL) |
Israel |
$0.179B |
0.00 |
Molecular Templates (MTEM) |
United States |
$0.165B |
0.00 |
Zafgen (ZFGN) |
United States |
$0.164B |
0.00 |
AcelRx Pharmaceuticals (ACRX) |
United States |
$0.163B |
0.00 |
Nature's Sunshine Products (NATR) |
United States |
$0.160B |
0.00 |
Aquestive Therapeutics (AQST) |
United States |
$0.160B |
0.00 |
Ardelyx (ARDX) |
United States |
$0.157B |
0.00 |
La Jolla Pharmaceutical (LJPC) |
United States |
$0.156B |
0.00 |
AgeX Therapeutics (AGE) |
United States |
$0.155B |
0.00 |
Ocular Therapeutix (OCUL) |
United States |
$0.152B |
0.00 |
Adherex Technologies (FENC) |
United States |
$0.148B |
0.00 |
Marinus Pharmaceuticals (MRNS) |
United States |
$0.148B |
0.00 |
Adamis Pharmaceuticals (ADMP) |
United States |
$0.147B |
0.00 |
Jounce Therapeutics (JNCE) |
United States |
$0.141B |
0.00 |
Neon Therapeutics (NTGN) |
United States |
$0.140B |
0.00 |
Cardiome Pharma (CORV) |
Canada |
$0.137B |
0.00 |
Bellicum Pharmaceuticals (BLCM) |
United States |
$0.136B |
0.00 |
MediWound (MDWD) |
Israel |
$0.127B |
0.00 |
Galmed Pharmaceuticals (GLMD) |
Israel |
$0.119B |
0.00 |
China SXT Pharmaceuticals (SXTC) |
China |
$0.118B |
0.00 |
Matinas Biopharma Holdings (MTNB) |
United States |
$0.117B |
0.00 |
ProNAi Therapeutics (SRRA) |
Canada |
$0.115B |
0.00 |
DURECT (DRRX) |
United States |
$0.112B |
0.00 |
Champions Oncology (CSBR) |
United States |
$0.111B |
0.00 |
Oasmia Pharmaceutical AB (OASM) |
Sweden |
$0.100B |
0.00 |
Cumberland Pharmaceuticals (CPIX) |
United States |
$0.091B |
0.00 |
Entasis Therapeutics Holdings (ETTX) |
United States |
$0.088B |
0.00 |
Iterum Therapeutics (ITRM) |
Ireland |
$0.084B |
0.00 |
Melinta Therapeutics (MLNT) |
United States |
$0.083B |
0.00 |
Natural Alternatives (NAII) |
United States |
$0.080B |
7.80 |
Infinity Pharmaceuticals (INFI) |
United States |
$0.077B |
0.00 |
Nivalis Therapeutics (ALPN) |
United States |
$0.077B |
0.00 |
Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.073B |
0.00 |
Immune Design (IMDZ) |
United States |
$0.070B |
0.00 |
Synergy Pharmaceuticals (SGYP) |
United States |
$0.070B |
0.00 |
Neos Therapeutics (NEOS) |
United States |
$0.068B |
0.00 |
Forward Pharma (FWP) |
Denmark |
$0.068B |
0.00 |
Zomedica Pharmaceuticals (ZOM) |
United States |
$0.066B |
0.00 |
SCYNEXIS (SCYX) |
United States |
$0.066B |
0.00 |
Achaogen (AKAO) |
United States |
$0.065B |
0.00 |
Tetraphase Pharmaceuticals (TTPH) |
United States |
$0.064B |
0.00 |
Avenue Therapeutics (ATXI) |
United States |
$0.063B |
0.00 |
KemPharm (KMPH) |
United States |
$0.062B |
0.00 |
Otonomy (OTIC) |
United States |
$0.062B |
0.00 |
Ampio Pharmaceuticals (AMPE) |
United States |
$0.062B |
0.00 |
Actinium Pharmaceuticals (ATNM) |
United States |
$0.061B |
0.00 |
Opiant Pharmaceuticals (OPNT) |
United States |
$0.056B |
0.00 |
CTI BioPharma (CTIC) |
United States |
$0.053B |
0.00 |
Mannatechorporated (MTEX) |
United States |
$0.046B |
0.00 |
Dipexium Pharmaceuticals (PLXP) |
United States |
$0.045B |
0.00 |
Genocea Biosciences (GNCA) |
United States |
$0.043B |
0.00 |
BioLineRx (BLRX) |
Israel |
$0.043B |
0.00 |
Tokai Pharmaceuticals (NVUS) |
United States |
$0.040B |
0.00 |
Capnia (SLNO) |
United States |
$0.036B |
0.00 |
ProPhase Labs (PRPH) |
United States |
$0.035B |
0.00 |
Lipocine (LPCN) |
United States |
$0.035B |
0.00 |
ContraFect (CFRX) |
United States |
$0.034B |
0.00 |
Heat Biologics (HTBX) |
United States |
$0.033B |
0.00 |
NOVAN INC (NOVN) |
United States |
$0.032B |
0.00 |
NanoViricides (NNVC) |
United States |
$0.029B |
0.00 |
IsoRay (ISR) |
United States |
$0.026B |
0.00 |
PharmAthene (ALT) |
United States |
$0.026B |
0.00 |
Biomerica (BMRA) |
United States |
$0.024B |
0.00 |
NovaBay Pharmaceuticals (NBY) |
United States |
$0.024B |
0.00 |
Can-Fite Biopharma (CANF) |
Israel |
$0.023B |
0.00 |
ESSA Pharma (EPIX) |
Canada |
$0.023B |
0.00 |
Xenetic Biosciences (XBIO) |
United States |
$0.020B |
0.00 |
Eyegate Pharmaceuticals (EYEG) |
United States |
$0.020B |
0.00 |
Trillium Therapeutics (TRIL) |
Canada |
$0.019B |
0.00 |
Pain Therapeutics (PTIE) |
United States |
$0.019B |
0.00 |
Citius Pharmaceuticals (CTXR) |
United States |
$0.019B |
0.00 |
Cyanotech (CYAN) |
United States |
$0.019B |
0.00 |
HANCOCK JAFFE (HJLI) |
United States |
$0.019B |
0.00 |
Kitov Pharmaceuticals Holdings (KTOV) |
Israel |
$0.018B |
0.00 |
Onconova Therapeutics (ONTX) |
United States |
$0.018B |
0.00 |
CollPlant Holdings Sponsored ADR (CLGN) |
Israel |
$0.018B |
0.00 |
Summit Therapeutics (SMMT) |
United Kingdom |
$0.018B |
0.00 |
Jaguar Animal Health (JAGX) |
United States |
$0.016B |
0.00 |
Auris Medical Holding AG (EARS) |
Switzerland |
$0.014B |
0.00 |
VAXART, INC (VXRT) |
United States |
$0.014B |
0.00 |
PRECISION THERAPEUTICS INC (AIPT) |
United States |
$0.014B |
0.00 |
OncoGenex Pharmaceuticals (ACHV) |
United States |
$0.012B |
0.00 |
XTL Biopharmaceuticals (XTLB) |
Israel |
$0.012B |
0.00 |
Shineco (TYHT) |
China |
$0.011B |
1.15 |
DelMar Pharmaceuticals (DMPI) |
Canada |
$0.010B |
0.00 |
Regulus Therapeutics (RGLS) |
United States |
$0.009B |
0.00 |
RXi Pharmaceuticals (PHIO) |
United States |
$0.007B |
0.00 |
Intellipharmaceutics (IPCI) |
Canada |
$0.006B |
0.00 |
Ohr Pharmaceuticals (OHRP) |
United States |
$0.006B |
0.00 |
Sonoma Pharmaceuticals (SNOA) |
United States |
$0.005B |
0.00 |
Bio Blast Pharma (ORPN) |
Israel |
$0.004B |
0.00 |
Ritter Pharmaceuticals (RTTR) |
United States |
$0.004B |
0.00 |
Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.003B |
0.00 |
Bio-Path Holdings (BPTH) |
United States |
$0.001B |
0.00 |
Advanced Accelerator Applications (AAAP) |
France |
$0.000B |
0.00 |
Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |